Your browser doesn't support javascript.
Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation.
Einarsdottir, Sigrun; Martner, Anna; Nicklasson, Malin; Wiktorin, Hanna Grauers; Arabpour, Mohammad; Törnell, Andreas; Vaht, Krista; Waldenström, Jesper; Ringlander, Johan; Bergström, Tomas; Brune, Mats; Hellstrand, Kristoffer; Ljungman, Per; Lagging, Martin.
  • Einarsdottir S; Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg.
  • Martner A; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Nicklasson M; Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg.
  • Wiktorin HG; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Arabpour M; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Törnell A; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Vaht K; Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg.
  • Waldenström J; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Ringlander J; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Bergström T; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Brune M; Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg.
  • Hellstrand K; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg.
  • Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Huddinge and Division of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm.
  • Lagging M; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg. martin.lagging@medfak.gu.se.
Haematologica ; 107(6): 1479-1482, 2022 06 01.
Article in English | MEDLINE | ID: covidwho-1875385
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Haematologica Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Haematologica Year: 2022 Document Type: Article